制度・支援
指定難病 — No.180

ATR-X症候群

検索語 Alpha-Thalassemia X-Linked Intellectual Disability Syndrome ・ 最終更新 2026-07-21 17:36 ・ 最新に更新

Data Sheet
指定 No.180
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

基礎研究(細胞・動物など)
MK-01 · PMID 42048321

ATRX function beyond hippocampal CA1 is required for cognitive deficits in mouse models of intellectual disability

Abstract / 原文

ATR-X syndrome, caused by mutations in the ATRX gene, leads to intellectual disability and neurodevelopmental deficits, with previous mouse models implicating forebrain ATRX loss in cognitive impairment. However, the region-specific requirements of neuronal ATRX for cognitive function remain unclear. Here, we generated conditional knockout mice with predominant deletion of ATRX in hippocampal CA1 pyramidal neurons in both pure C57Bl/6J and hybrid C57Bl/6J + 129S2/Sv genetic backgrounds. Immunofluorescence confirmed efficient ATRX loss in CA1 neurons, with mosaic expression throughout other forebrain structures. Behavioral analyses revealed that T29-1 CaMKIIα-Cre ATRX knockout mice exhibited significant hypoactivity and increased anxiety traits, particularly in the open field, but retained normal hippocampal-dependent contextual fear memory and spatial learning and memory. In contrast, we confirmed that mice with robust forebrain-wide ATRX ablation in excitatory neurons (R1ag#5 CaMKIIα-Cre-mediated) displayed deficits in these cognitive domains. Our findings demonstrate that ATRX-related intellectual disability requires disruption of broader hippocampal or forebrain circuits to elicit cognitive impairments in learning and memory.

Journal
PloS one(2026)
Authors
2名
Type
Journal Article
PubMedで原文を見る
基礎研究(細胞・動物など)
MK-02 · PMID 41724591

Altered Brain Structure in an ATRX-Deficient Mouse Model of Autism Spectrum Disorder

Abstract / 原文

Mutations in the ATRX gene are a primary cause of alpha-thalassemia intellectual disability X-linked (ATRX) syndrome, which is characterized by intellectual disability, autism, and a range of brain structural abnormalities, including microcephaly. We previously showed that mice with conditional ATRX ablation in forebrain excitatory neurons display deficits in fear memory and autism-related behaviors, with some effects exhibiting sexual dimorphism. In this study, we used high-resolution magnetic resonance imaging (MRI) to systematically characterize brain structural changes associated with these behavioral abnormalities. Whole-brain analysis revealed male-specific microcephaly, while subregional analysis identified significant reductions in hippocampal structures and increased volume of the caudal cortex in mutant animals of both sexes. We also identified structural alterations in regions retaining ATRX expression, such as the thalamus, midbrain, cerebellum, and several fiber tracts. These findings suggest that ATRX loss disrupts the coordinated development of interconnected brain regions. Overall, our results implicate impaired cortico-thalamic-cerebellar connectivity as a potential neural substrate underlying the autistic-like behaviors observed in this mouse model, providing new insights into the neurobiological basis of ATR-X syndrome.

Journal
Autism research : official journal of the International Society for Autism Research(2026 Apr)
Authors
4名
Type
Journal Article
PubMedで原文を見る
不明
MK-03 · PMID 41606192

Type I interferonopathy in ATR-X syndrome reveals a transcriptional role for cGAS

Journal
Nature reviews. Immunology(2026 Mar)
Authors
2名
Type
Journal Article
PubMedで原文を見る
基礎研究(細胞・動物など)
MK-04 · PMID 41239822

Astrocytic Chromatin Remodeler ATRX Gates Hippocampal Memory Consolidation Through Metabolic and Synaptic Regulation

Abstract / 原文

Astrocytes are increasingly recognized as active regulators of synaptic transmission and memory, yet the epigenetic mechanisms underlying their contribution to cognitive processes remain poorly defined. Here, we investigated the role of the chromatin remodeler ATRX in astrocytes by generating mice with inducible, astrocyte-specific Atrx deletion (aiKO) using tamoxifen administration at postnatal days 10-12, resulting in ATRX loss in approximately half of hippocampal and cortical astrocytes. Transcriptomic profiling of hippocampal tissue at 1 and 3 months revealed differentially expressed genes, with early enrichment for cytoskeletal and immune pathways and later dysregulation of energy metabolism, ion transport, and synaptic gene sets. Electrophysiological recordings from CA1 pyramidal neurons in aiKO slices demonstrated increased neuronal excitability and decreased frequency of spontaneous excitatory postsynaptic currents, indicating non-cell-autonomous neuronal dysfunction. Morphological analysis identified a transient reduction in dendritic branching at 1 month and a selective loss of thin dendritic spines by 3 months, without changes in total dendrite length or overall spine density. Behaviorally, aiKO mice displayed normal locomotion, anxiety, and short-term memory, but exhibited deficits in 24-h novel object recognition and long-term spatial memory in the Morris water maze. These findings demonstrate that ATRX-mediated chromatin remodeling in astrocytes is essential for maintaining hippocampal transcriptional homeostasis, neuronal function, and long-term memory. Our results highlight a critical role for astrocytic epigenetic regulation in cognitive processes and suggest that astrocyte dysfunction may contribute to the pathogenesis of ATR-X syndrome and related intellectual disability disorders, underscoring the importance of targeting multiple cell types for therapeutic intervention.

Journal
Glia(2026 Jan)
Authors
7名
Type
Journal Article, Research Support, Non-U.S. Gov't
PubMedで原文を見る
観察研究
MK-05 · PMID 41222108

ATRX: From Chromatin Remodeling to Disease

Abstract / 原文

Chromatin remodeling proteins are evolutionarily conserved factors involved in a wide range of biological processes. In this review, we describe ATRX, a chromatin remodeling protein belonging to the SWI/SNF2 family. Its association with different protein complexes, and its roles in embryonic development, sexual differentiation, as well as retinal and brain function. We further discuss and integrate current findings on pathologies associated with ATRX dysfunction such as ATR-X syndrome, focusing on its etiology, clinical features, and potential diagnostic tools. Finally, we propose that ATRX may contribute to the progression of certain neurodegenerative diseases and review recent literature supporting this hypothesis.

Journal
Genesis (New York, N.Y. : 2000)(2025 Dec)
Authors
2名
Type
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件をご確認ください。

※ jRCTは自動の大量データ取得を禁じているため、本サービスはjRCTを自動収集せず、患者ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度ATR-X症候群の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。